Search - tctmd.com

Displaying 1 - 14 of 14

Sort: Relevancy | Date

Presentation Cell Therapy 2014

Dynamic Components and Endpoints of Pivotal Trials for Heart Failure

Presenter: James E. Udelson

January 23, 2014

Presentation Cell Therapy 2014

MPC’s for Ischemic and Non-ischemic Heart Failure

Presenter: Emerson C. Perin

January 22, 2014

Presentation Cell Therapy 2014

Repetitive BMC Therapy in Chronic Heart Failure: Rationale and Design of the REPEAT Trial

Presenter: Birgit Assmus

January 22, 2014

Presentation Cell Therapy 2014

LV Augmentation for the Treatment of Heart Failure

Presenter: Randy Lee

January 22, 2014

Presentation Cell Therapy 2014

A breakthrough in regenerative therapies for Heart Failure

Presenter: Frank Ahmann

January 21, 2014

Presentation Cell Therapy 2013

SDF-1: Final Results of a Phase 1 Trial and Status of STOP-HF Study

Presenter: Marc S. Penn

January 22, 2013

Presentation Cell Therapy 2013

MPC's for Ischemic and Nonischemic Heart Failure

Presenter: Emerson C. Perin

January 22, 2013

Presentation Cell Therapy 2013

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells (Revascor™) in Patients With Chronic Heart Failure of Ischemic or Nonischem

Presenter: Kenneth M. Borow

January 22, 2013

Presentation Cell Therapy 2013

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells

Presenter: Kenneth Borow

January 22, 2013

Presentation Cell Therapy 2013

CD-34+ Cells for Ischemic Heart Failure

Presenter: Bojan Vrtovec

January 22, 2013

Presentation Cell Therapy 2012

Regenerative Therapy for Heart Failure: Lessons Learned and Unanswered Questions

Presenter: Les Miller

January 26, 2012

Presentation Cell Therapy 2012

SDF-1 for Heart Failure: One-Year Results of a Phase I Trial

Presenter: Marc S. Penn

January 25, 2012

Presentation Cell Therapy 2012

JD200 for Heart Failure: Safety Study

Presenter: Amit Patel

January 25, 2012

Presentation Cell Therapy 2012

Early and Next Phase Studies: Augment-HF Trial

Presenter: Randy Lee

January 25, 2012

Advertisement

Dynamic Components and Endpoints of Pivotal Trials for Heart Failure

MPC’s for Ischemic and Non-ischemic Heart Failure

Repetitive BMC Therapy in Chronic Heart Failure: Rationale and Design of the REPEAT Trial

LV Augmentation for the Treatment of Heart Failure

A breakthrough in regenerative therapies for Heart Failure

SDF-1: Final Results of a Phase 1 Trial and Status of STOP-HF Study

MPC's for Ischemic and Nonischemic Heart Failure

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells (Revascor™) in Patients With Chronic Heart Failure of Ischemic or Nonischem

Clinical Outcomes and Surrogate Efficacy Data for a Phase II Dose-Escalation Study of Allogeneic Mesenchymal Precursor Cells

CD-34+ Cells for Ischemic Heart Failure

Regenerative Therapy for Heart Failure: Lessons Learned and Unanswered Questions

SDF-1 for Heart Failure: One-Year Results of a Phase I Trial

JD200 for Heart Failure: Safety Study

Early and Next Phase Studies: Augment-HF Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content